Clinical trial
Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA…
NCT00327613 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00327613 |
|---|---|
| Title | Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma |
| Official title | Plasma Levels of Matrix Metalloproteinases and Degree of DNA Fragmentation in Patients With Pseudoexfoliation Syndrome and Open-Angle Glaucoma (PEXG) |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Pseudoexfoliation Syndrome, Glaucoma |
| Enrollment | 60 |
| Start date | Jun 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 18, 2006 |
| Last update posted | Sep 26, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: